Kolexia
Ardillon Laurent Biologie médicale
Ardillon Laurent
Biologie médicale
Hôpital Trousseau Chambray lès Tours
Chambray-lès-Tours, France
50 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Maladies de von Willebrand Hémophilie B Athérosclérose Fibrillation auriculaire Déficit en facteur V Hémarthrose Drépanocytose

Collaborateurs

Voir plus
Trossaert Marc
Trossaert Marc
Hôpital Hôtel-Dieu Nantes, Nantes, France
Pan-Petesch Brigitte
Pan-Petesch Brigitte
Hôpital Morvan, Brest, France
Guillet Benoit
Guillet Benoit
Hôpital Pontchaillou, Rennes, France
Valentin Jean-Baptiste
Valentin Jean-Baptiste
Hôpital Trousseau Chambray lès Tours, Chambray-lès-Tours, France

Industries

Voir plus
Sobi
4 collaboration(s)
Dernière en 2023
KEPHREN PUBLISHING
2 collaboration(s)
Dernière en 2023
Octapharma
1 collaboration(s)
Dernière en 2022
LFB
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Hémophilie
HAS Publications   20 juin 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023
SENIORHEMO: Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   07 juin 2023
TRANSHEMO: Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 février 2023
GIDEMHA: Retrospective, Observational and Multicenter Study of Factors Influencing the Pharmacokinetic of the Factor VIII After Intravenous Desmopressin in Patients With Moderate or Minor Hemophilia A
Essai Clinique (Groupe Maladies hémorragiques de Bretagne)   24 novembre 2022
GENDYSFIB: Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
Essai Clinique (CHU Clermont-Ferrand)   11 octobre 2022
rFVIII-Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings.
European journal of clinical investigation   27 juin 2022
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis.
Haemophilia : the official journal of the World Federation of Hemophilia   14 avril 2022
Tissue Factor Pathway Inhibitor (TFPI) Levels and Bleeding Risk in Patients with Severe Hemophilia A or B
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Real-world Use of FVIII in People with Severe Hemophilia A without Inhibitor on Prophylaxis, Comparing Switched to rFVIII-Fc versus Non-switched Patients: A Multicentre, Retrospective, Non Interventional, before-after Study with the French Nationwide Claims Database (MOTHIF-II)
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021